Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,020,909
-
Total 13F shares
-
50,360,102
-
Share change
-
+1,349,734
-
Total reported value
-
$10,157,640,692
-
Put/Call ratio
-
116%
-
Price per share
-
$201.82
-
Number of holders
-
601
-
Value change
-
+$259,182,756
-
Number of buys
-
300
-
Number of sells
-
266
Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) as of Q1 2023
As of 31 Mar 2023,
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) was held by
601 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
50,360,102 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Clearbridge Investments, LLC, Allspring Global Investments Holdings, LLC, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, and Jackson Square Partners, LLC.
This page lists
608
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.